Key Details
Price
$86.95Last Dividend
$0.04Annual ROE
18.55%Beta
0.88Events Calendar
Next earnings date:
Feb 13, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 06, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Jan 14, 2025Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
GE HealthCare Technologies, which became independent from General Electric in 2023, has experienced impressive stock growth, surpassing the S&P 500 significantly. Although its financial results have been mixed, the company is still considered undervalued compared to its rivals and has opportunities for further expansion in a growing market. The management's positive outlook for 2024 and future years, along with smart investments and partnerships, indicates potential for ongoing revenue and profit increases.
CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare is investing $138 million in a manufacturing plant in Cork, Ireland, to meet the growing demand for contrast media.
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has been included in the 2025 Fortune World's Most Admired Companies™ list. The company received recognition in various areas such as management quality, product and service excellence, innovation, long-term investment value, financial stability, talent management, and commitment to community and environmental issues. This acknowledgment highlights GE HealthCare's strong global business practices and effective use of corporate resources.
Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com has included the report titled "China External Cardiology Remote Monitors Market Outlook to 2033." This detailed databook offers important market information about the External Cardiology Remote Monitors sector in China, including value (in USD), volume (in units), and average prices (in USD) across different market segments. The report presents essential data and insights regarding the China External Cardiology Remote Monitors Market.
GEHC's ongoing emphasis on new ideas, buying other companies, and forming partnerships creates a positive outlook for the stock.
GE HealthCare has revealed a seven-year partnership with Sutter Health.
Investors looking at Medical - Products stocks probably know about GE HealthCare Technologies (GEHC) and Insulet (PODD). However, which of these two stocks is more appealing for value investors?
SACRAMENTO, Calif.--(BUSINESS WIRE)--Sutter Health and GE HealthCare (Nasdaq: GEHC) have revealed a seven-year partnership called a Care Alliance. This collaboration aims to improve access to advanced imaging services and enhance the experience for both clinicians and patients within the Sutter Health system. The partnership will expand access to important diagnostic care throughout California, offering patients cutting-edge technology.
The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons why you should make use of this tool.
GE HealthCare Technologies Inc. (GEHC) shares saw an increase in value on Wednesday. Jefferies upgraded the stock from Hold to Buy and raised the price target from $95 to $103.
FAQ
- What is the primary business of GE HealthCare Technologies?
- What is the ticker symbol for GE HealthCare Technologies?
- Does GE HealthCare Technologies pay dividends?
- What sector is GE HealthCare Technologies in?
- What industry is GE HealthCare Technologies in?
- What country is GE HealthCare Technologies based in?
- When did GE HealthCare Technologies go public?
- Is GE HealthCare Technologies in the S&P 500?
- Is GE HealthCare Technologies in the NASDAQ 100?
- Is GE HealthCare Technologies in the Dow Jones?
- When was GE HealthCare Technologies's last earnings report?
- When does GE HealthCare Technologies report earnings?
- Should I buy GE HealthCare Technologies stock now?